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Abnormal Fear Conditioning and Amygdala Processing
in an Animal Model of Autism
Kamila Markram*,1, Tania Rinaldi1, Deborah La Mendola1, Carmen Sandi1 and Henry Markram1
1Brain Mind Institute, Swiss Federal Institute of Technology (EPFL), Lausanne, Switzerland
A core feature of autism spectrum disorders is the impairment in social interactions. Among other brain regions, a deficit in amygdala
processing has been suggested to underlie this impairment, but whether the amygdala is processing fear abnormally in autism, is yet not
clear. We used the valproic acid (VPA) rat model of autism to (a) screen for autism-like symptoms in rats, (b) test for alterations in
amygdala-dependent fear processing, and (c) evaluate neuronal reactivity and synaptic plasticity in the lateral amygdala by means of in vitro
single-cell electrophysiological recordings. VPA-treated animals displayed several symptoms common to autism, among them impaired
social interactions and increased repetitive behaviors. Furthermore, VPA-treated rats were more anxious and exhibited abnormally high
and longer lasting fear memories, which were overgeneralized and harder to extinguish. On the cellular level, the amygdala was
hyperreactive to electrical stimulation and displayed boosted synaptic plasticity as well as a deficit in inhibition. We show for the first time
enhanced, overgeneralized and resistant conditioned fear memories in an animal model of autism. Such hyperfear could be caused by the
hyperreactivity and hyperplasticity found in the lateral amygdala, which may in turn be due to a deficit in the inhibitory system of the
amygdala. We hypothesize an ‘aversive world’ syndrome that could, even if not a primary cause of the disorder itself, underlie some core
symptoms in autism, such as impairments in social interactions and resistance to rehabilitation.
Neuropsychopharmacology (2008) 33, 901–912; doi:10.1038/sj.npp.1301453; published online 16 May 2007
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INTRODUCTION
Autism is one of the fastest growing developmental
disorders characterized by inhibited reciprocal social
interactions, communication deficits and marked inflex-
ibility to environmental changes, which makes rehabilita-
tion exceedingly difficult. Several brain structures and
pathways have been suggested to underlie this disorder,
among them the amygdala (Bachevalier, 1994; Baron-Cohen
et al, 1999; Adolphs et al, 2001), which exhibits a number of
abnormalities. Whereas earlier postmortem studies on
autistic patients indicated an increased number of cells
with reduced cell size in the cortical, medial, and central
nuclei of the amygdala (Kemper and Bauman, 1998), more
recent and modern stereological counts of neurons in the
amygdala revealed a reduced number of neurons, particu-
larly in the lateral nucleus (Schumann and Amaral, 2006).
The total amygdala volume is enlarged during early infancy
(Sparks et al, 2002; Schumann et al, 2004), but can be
reduced in adulthood (Aylward et al, 1999). Functionally,
the amygdala has been linked to autism through its
involvement in socio-emotional behavior. Neuroimaging
studies indicate that the amygdala does not activate
sufficiently when subjects view faces or judge feelings and
thoughts from faces (Baron-Cohen et al, 1999; Critchley
et al, 2000; Pierce et al, 2001), which may indicate weak
amygdala functioning in autism. Monkey studies seem to
support this hypothesis as amygdala-lesioned monkeys
withdraw socially, fail to initiate and respond to social
behaviors (Kling and Brothers, 1992), and exhibit flat
vocalizations that lack affect (Newman and Bachevalier,
1997). However, the hypothesis that the amygdala plays a
fundamental role in the generation of social behavior has
been questioned more recently (Amaral et al, 2003) and
there might be an alternative view on the involvement of the
amygdala in autism. Kanner’s original (Kanner, 1943) and
other more recent studies (Muris et al, 1998; Gillott et al,
2001; Evans et al, 2005) suggest that abnormal anxiety, fears
and phobias are also traits of autism, and the amygdala has
been extensively linked to both anxiety and conditioned
fear, in humans and in animals (Davis and Whalen, 2001;
LeDoux, 2003). Thus, it is possible that abnormal proces-
sing in the amygdala might be central to the generation of
these excessive fears observed in autism.
To test this hypothesis, we assessed fear processing in the
valproic acid (VPA) rat model of autism (Rodier et al,
1996). VPA is one of the teratogens implicated in causing
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autism in humans (Christianson et al, 1994; Williams and
Hersh, 1997; Moore et al, 2000; Williams et al, 2001;
Rasalam et al, 2005), when administered around the critical
time period of neural tube closure (embryonic day 20–24;
Arndt et al, 2005). In rats, a single intraperitoneal (i.p.)
injection of VPA to the pregnant dam at a corresponding
time of embryonic day 12.5 tends to produce a neuroana-
tomical and behavioral phenotype similar to the human
condition. Offspring of treated dams exhibit brain stem
injuries, diminished number of Purkinje cells in the
cerebellum, impaired social interaction, increased repetitive
behavior, increased nociceptive thresholds, increased sensi-
tivity to complex sensory stimulation, and enhanced anxiety
(Rodier et al, 1996, 1997; Ingram et al, 2000; Schneider and
Przewlocki, 2005; Schneider et al, 2006), all symptoms that
are common to autism.
The present study had three approaches: first, animals
were screened for autism-like symptoms to further validate
the VPA rat model of autism. Second, amygdala function
was evaluated on the behavioral level by assessing fear
memories and fear processing. Finally, the amygdala was
evaluated on the electrophysiological level to check for
possible alterations in neuronal processing and synaptic
plasticity.
The results were previously presented in abstract and
poster form at Society for Neuroscience and Federation of
European Neurosciences conferences (Markram et al, 2005;
La Mendola et al, 2006).
MATERIALS AND METHODS
Valproic Acid Model of Autism
Wistar Han rats (Charles River Laboratories, L’Arbresle,
France) were mated and pregnancy was determined by the
presence of a vaginal plug on embryonic day 1 (E1). Sodium
salt of valproic acid (NaVPA, Sigma) was dissolved in 0.9%
saline for a concentration of 150 mg/ml (pH 7.3). The dosing
volume was 3.3 ml/kg; the dosage was adjusted according to
the body weight of the dam on the day of injection. Treated
dams received a single ip injection of 500 mg/kg NaVPA and
control dams a single ip injection of saline on E12.5. Dams
were housed individually and were allowed to raise their
own litters until weaning (postnatal day P23). The offspring
was then separated and housed in cages of 3–4 rats until the
start of behavioral experiments (approximately 3 months
after birth). Electrophysiological experiments were con-
ducted on P12–P16. Overall, for behavioral procedures, 274
male and female rat offspring (136 controls, 138 VPA-
treated) from 36 litters (16 control, 20 VPA-treated) were
tested. In electrophysiological experiments, 13 male rat
offspring (six controls, seven VPA-treated) from 11 litters
(six control, five VPA-treated) were tested. The birth rate
was approximately 25% lower in VPA- than saline-injected
dams, which was reflected in lower weight of the dams
during pregnancy. Whereas there were no differences
in weight before the injection (saline: 277.7 g74.0; VPA:
283.9 g72.4; t14¼1.40, p¼ 0.18), saline-injected dams
gained significantly more weight 5 days after the injec-
tion than VPA-injected dams (saline: 50.2 g73.1; VPA:
15.7 g72.5; t14¼ 8.84, po0.000).
All the procedures described were conducted in con-
formity with the Swiss National Institutional Guidelines
on Animal Experimentation on the ethical use of animals,
and approved by the Swiss Cantonal Veterinary Office
Committee for Animal Experimentation.
Social Interaction
Rats were separated and housed individually the night
before the experiment to enhance later social interactions.
The apparatus was a white plastic box (50 40 40 cm)
containing a plastic tube big enough for a rat to hide inside.
Rats were matched for their gender and weight. Pairs of
either treated or control rats were put into the apparatus
over a period of 20 min. The percent time spent pinning
(one rat lies on its back, the other stands with two paws on
top of it), following, touching, grooming each other, sniffing
of any body part besides of anogenital parts, sniffing of the
anogenital body parts and hiding inside the tube during the
first and second 10 min were taken as indicators of social
engagement.
Repetitive Behavior
Rats were tested in the spontaneous alteration paradigm.
Rats were inserted individually into the start arm of a
standard Y-maze (gray polyvinyl plastic) and allowed to
move freely on each of two trials. On trial 1, the animal was
allowed to enter either arm, neither of which was rewarded,
and remain there for 5 s. The rat was then returned to
the start arm and the subsequent arm choice was recorded
(trial 2). The percentage of rats per group re-entering the
same arm was taken as an indicator for repetitive behavior.
Nociception
Thermal pain sensitivity was measured with the hot plate
test (TSE, Bad Homburg, Germany). The plate was set to a
temperature of 501C and the latency to a discomfort
reaction (paw withdrawal) was measured. Cut-off time was
1 min.
Startle Response and Prepulse Inhibition
Acoustic startle reflex amplitude and prepulse inhibition
(PPI) were measured with the SR-Lab System (San Diego
Instruments, CA, USA). The equipment included response
platforms that were individually calibrated and placed in
sound attenuating chambers. Each chamber was equipped
with an internal light, fan, and sound generation system.
Plexiglas cylinders large enough to hold adult rats with
minimal restraint were mounted on the platforms. The
white background noise was adjusted to a constant 70 dB.
The test session was conducted in three blocks and
started with a 5 min acclimation period. Block 1 consisted of
five startle-only trials with a 115 dB acoustic stimulus pulse
(startle tone). Block 2 had a total of 36 trials: 12 startle-only
trials as in block 1 and 24 prepulse plus startle trials,
conducted under four different conditions: the intensity of
the prepulse was either 78 or 86 dB and the prepulse to
startle tone interval was either 30 or 120 ms. The trials were
presented in random order with the intertrial duration
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ranging from 10 to 20 s. Block 3 had an additional five
startle-only trials. Each stimulus had a 2 ms rise/fall time.
The entire test period lasted approximately 25 min.
Anxiety
Rats were inserted for 5 min in a standard elevated plus-
maze, which consisted of two opposite open arms and two
opposite closed arms (49 10 42 cm) arranged at right
angles. The percent time spent in the open and closed arms
indicated anxiety levels and the total distance (cm) moved
and velocity (cm/s), with which rats moved through the
entire maze, indicated locomotor and exploration capabi-
lities.
Fear Conditioning
Fear conditioning occurred in a standard fear conditioning
apparatus (Panlab, Barcelona, Spain). The floor consisted of
20 steel rods through which a scrambled shock could be
delivered. The sidewalls of the observation cage were of
black stainless steel and the door of Plexiglas. Auditory fear
conditioning (AFC) training started with a 160 s habituation
period, followed by three 1 mA shocks (inter-shock interval:
60 s), each paired with a 20 s tone (800 Hz, 80 dB). Ethanol
(4%) was used for cleaning in between training sessions.
Fear memories to the context were assessed by putting the
rats for 8 min into exactly the same context as during
training, but without shocks. To measure fear memories to
the tone, visual (green plastic walls) and odor (4% clorine)
cues in the conditioning chamber were exchanged and rats
remained in the chamber for 8 min, during which the tone
was continuously on for the last 5 min. The percent time
spent freezing during the 8 min context and 5 min tone
memory test were taken as indicators of fear. Fear memories
to the context and tone were assessed on two successive
days, starting 1 day, 30 and 90 days post-training.
Fear generalization to a novel context and tone was
performed on day 4 and assessed as in the tone memory
test, just that the tone was additionally changed as well
(400 Hz, 80 dB). Freezing during the first 3 min indicated
fear generalization to a novel context and during the last
5 min to a novel tone.
To assess fear extinction, the same animals that were
previously evaluated for fear memories were divided into
three groups and were first re-conditioned (three shocks,
0.5 mA) either to the context alone (contextual fear
conditioning (CFC)) or paired with a tone (as above) 1
day after the last memory test. Fear extinction was then
conducted under three conditions: the group that received
CFC was extinguished to the same context on four
subsequent days, starting with an 8 min pre-extinction
context test, followed by two days of 30 min further context
exposure and ending with another 8 min post-extinction
context test. Rats, which received AFC, were extinguished in
either the same or a different context as during training.
The procedure was as above: first a 5 min pre-extinction
tone memory test was conduced, followed by two extinction
sessions (each 30 min in which a 20 s tone alternated with
40 s silence) and finally a 5 min post-extinction tone test.
For each animal in all conditions, an extinction index was
computed describing the percentual decrease in freezing
from pre-extinction (¼ baseline) to post-extinction test
(freezing post-extinction/freezing pre-extinction 100).
Morris Water Maze
The water maze apparatus consisted of a large circular pool
(2.05 m in diameter) filled with water (25711C). A platform
(11 cm diameter) was submerged 1 cm under the water
surface. Both pool and platform were made of black
polyvinyl plastic and offered no intramaze cues to guide
escape behavior. The water maze was surrounded with
curtains containing several extramaze visual cues.
Rats received 4 days of spatial training, each session
consisting of four trials (intertrial interval (ITI): 30 s). Each
trial started with the rat facing the wall at one of four
possible positions. The latency to find the platform was
measured. If a rat did not find the platform within 90 s, it
was guided towards it. Each rat remained on the platform
for 15 s before it would be taken out. On day 5, a probe test
was conducted, in which the platform was removed from
the pool and animals were released to the pool for a 60-s
period from the quadrant opposite to the one where the
platform had been previously located. At the end of the
probe trial the platform was re-inserted into the pool and
rats remained on it for 15 s.
Video tracking software (Ethovision, Noldus, The Nether-
lands) was used for automatic recording and analysis of
escape latencies, distances swum and velocities in case of
the spatial training sessions and percentage of time spent
and distance swum in the target quadrant, number of virtual
platform crossings, and latency to reach the virtual platform
in case of the probe trial.
Acute Slice Preparation for In Vitro Electrophysiology
Rats (P12–P16) were rapidly decapitated and coronal
amygdala slices (300 mm thick) were sectioned on a
vibratome (HR2, Sigmann Elektronik) in iced artificial
cerebral spinal fluid (ACSF, contained (mM): 125 NaCl, 2.5
KCl, 25 glucose, 25 NaHCO3, 1.25 NaH2PO4, 2 CaCl2 and 1
MgCl2). Slices were incubated for 30 min at 351C and then at
room temperature until transferred to the recording
chamber (room temperature or 341C). Neurons in the
lateral amygdaloid nucleus (LA) were identified using IR-
DIC microscopy, with an upright microscope (Olympus
BX51WI, fitted with a 60 /0.90 W objective, Olympus,
Switzerland). Recorded neurons were selected up to 70 mm
below the slice surface.
Electrophysiological Recording
Simultaneous whole-cell recordings from clusters of up to
four pyramidal neurons (pipette resistance 4–10 MO) were
made in the LA and signals were amplified using Axopatch
200B amplifiers (Axon Instruments, CA, USA). Voltages (in
current-clamp mode) or currents (in voltage-clamp mode)
were recorded with pipettes containing (in mM): 110
potassium gluconate, 10 KCl, 4 ATP-Mg, 10 phospho-
creatine, 0.3 GTP, 10 Hepes, and 0.5% biocytin (pH 7.3,
270–300 mOsm). Membrane potentials were not corrected
for the junction potentials between pipette and bath
solution (B10 mV).
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Multi-Electrode Array Stimulation
Mea stimulation. Multisite extracellular stimulations were
performed using a multi-electrode array (MEA) made of 60
3D platinum electrodes (Ayanda Biosystems, EPFL, Switzer-
land), on top of which acute brain slices were glued with a
nitrocellulose solution (0.14 mg/ml in ethanol). Responses
to these MEA stimulations were recorded in whole-cell
patched pyramidal cells in LA. To study the effects of
network stimulation, 16 MEA electrodes were stimulated
simultaneously with a Poisson train (50 Hz, 300 ms) at
increasing stimulation amplitude (0.1–2 V). Whole-cell
voltage-clamped cells were then recorded at 80 mV
(reversal potential of GABA receptors) to study excitatory
effects and at + 10 mV (reversal potential of AMPA
receptors) for the isolation of inhibitory inputs.
Long-Term Potentiation
An extracellular electrode was placed 100–300 mm medial to
the LA in the ventral striatum (Bauer et al, 2002). Whole-
cell patched pyramidal cells were recorded in the LA.
Calibration procedures for long-term potentiation (LTP)
recordings were conducted according to Bauer et al (2002).
A stimulation pulse of an amplitude producing a response
of a few millivolts in the I-clamped patched cell was given
before the pairing protocol, and the maximum amplitude of
the mean of 30 traces was measured. The 3 s long pairing
protocol consisted of a 30 Hz regular train stimulation to
the extracellular electrode simultaneously with a depolari-
zation above threshold of the patched cell, applied three
times at 30 s intervals. The response to the stimulation pulse
was then monitored up to 30 min after the initial recording
(three sets of 30 stimulation pulses every 10 s, with 5 min
interval between each set). The percent increase in the
response amplitude to the stimulation pulse after pairing
compared to before pairing was measured.
Statistical Analysis
For comparison of rates and means, two-sided w2 and
Student’s t-tests were used, respectively. ANOVA for
repeated measurements was applied when sequences were
evaluated (social interaction, spatial training sessions on
each of the 4 days, network inhibition at increasing
stimulation amplitudes). Post-hoc analysis was performed
with Student’s t-tests. Statistics reported in the text and
figures represent the mean7SEM.
RESULTS
Behavioral Validation of the VPA Model of Autism
Before exploring fear processing in the VPA rat model, we
first wanted to test whether the behavioral deficits
previously reported (Schneider and Przewlocki, 2005), were
reproduced in our animals.
Impaired social interaction. For social interaction, we
evaluated how pairs of unfamiliar VPA-treated or control
animals interacted freely for 20 min in a box containing
an escape tube large enough for a rat. Treated animals
exhibited less play behavior (pinning, F1,18¼ 8.14,
p¼ 0.01), explored each other less, as indicated by sniff-
ing (F1,18¼ 23.21, po0.000) and touching each other
(F1,18¼ 4.25, p¼ 0.05), and avoided interaction by hiding
more in the tube than control animals (F1,18¼ 4.25,
p¼ 0.05), but did not differ from control animals in their
grooming (F1,18¼ 1.94, p¼ 0.2) and anogenital inspections
(F1,18¼ 0.51, p¼ 0.58; n¼ 10 pairs/group; Figure 1a) of each
other. Therefore, VPA-treated rats show deficits in some,
but not all of the social interaction behaviors performed by
rats.
Increased repetitive behavior. Repetitive behavior was
tested in a spontaneous alternation task in the Y-maze
(Kahne et al, 2002), which is thought to reveal obsessive-
compulsive-like behaviors (Yadin et al, 1991). Once the rat
entered and briefly explored one of the two possible arms in
the first trial, it was re-put into the starting position for the
second trial and the entrance into either a novel or the same
arm previously entered was monitored. Normally, rats
prefer to explore a novel arm in the second trial. In
accordance with this, only 24% of the control rats (n¼ 43)
re-entered the same arm. However, 51% of treated rats
(n¼ 35) re-entered the same arm (w21¼ 6.05, p¼ 0.01;
Figure 1b), suggestive of repetitive tendencies.
Impaired thermal nociception. VPA-treated offspring
(n¼ 39) exhibited highly significantly higher latencies to
withdraw the hindpaw in the hot plate test than controls
(n¼ 36) (t73¼ 4.62; p¼ 0.000), indicating impaired sensi-
tivity to thermal pain.
Intact sensory processing, but impaired sensorimotor
gating. As increased sensitivity to sensory stimulation is
also symptomatic of autism, we measured the startle
response to a tone alone (115 dB, the startle tone). Further,
we examined PPI, that is, when the tone was preceded by
another less-intense tone (a prepulse tone). In this
configuration the softer prepulse inhibits the response to
the second louder tone and the response is smaller than
when the sound is presented on its own, which may be
interpreted as sensory habituation and/or response inhibi-
tion. There was no difference in response to the startle tone
between control (n¼ 58) and treated (n¼ 56) animals
(t112¼ 0.01, p¼ 0.99; Figure 1c), suggesting no deficit in
single or simple sensory stimulation. The prepulse inhibi-
tion was however decreased in all four conditions and
reached significance in two conditions (78 dB, 120 ms
prepulseFstartle tone interval: t112¼2.17, p¼ 0.03;
86 dB, 120 ms prepulseFstartle tone interval: t112¼2.10,
p¼ 0.04; Figure 1c), suggesting a lack of inhibition of a
subsequent tone, which may be indicative of hypersensi-
tivity to subsequent or complex sensory stimuli.
Increased anxiety. Next, we examined anxiety levels in a
standard elevated plus-maze. Treated (n¼ 52) animals
spent 35% less time in the open arms (t109¼2.11,
p¼ 0.04; Figure 1c) and 14% more time in the closed arms
(67%73 for control; 77%73 for treated; t109¼ 2.46,
p¼ 0.01) than controls (n¼ 59), indicating increased
anxiety in the VPA animals. This effect was not due to
broad locomotor deficits as both total distances moved and
average velocities, with which the animals moved through
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the maze, were the same (distance: t109¼0.34, p¼ 0.74;
velocity: t109¼0.56, p¼ 0.58; Figure 1d).
In summary, offspring of VPA-treated dams exhibited
less social interactions, increased stereotypic, and repetitive
tendencies, and less sensitivity to pain. Locomotion levels
and reactions to simple auditory stimulation were normal in
treated animals. However, more complex auditory stimula-
tion in the PPI paradigm revealed impaired sensory
habituation and/or response inhibition. Anxiety levels were
increased in VPA-treated offspring, which indicated abnor-
mal amygdala processing (Shekhar et al, 2005).
Fear Processing
Enhanced fear memories. During training, rats were
exposed to three electric shocks (1 mA, 1 s every 60 s)
preceded by a tone (20 s, 800 Hz, 80 dB), which co-
terminated with the shock. Treated and control animals
exhibited the same freezing levels in the shock period
during training (t150¼ 1.32, p¼ 0.19; n¼ 76 animals/group;
Figure 2a), indicating normal fear acquisition and no
differences in sensitivity to the shocks.
Fear memories were measured on two subsequent days
starting 1, 30 and 90 days after fear conditioning for the
context in which the fear was acquired, and the tone alone
when presented in a novel context. Conditioned fear
memory to both, tone and context, was highly elevated in
VPA-treated animals at all time points measured, with the
differences between groups becoming more striking with
time, reaching up to 46% higher freezing after 3 months
(tone: day 3, t150¼ 2.92, p¼ 0.004; day 31, t140¼ 4.32,
po0.0000; day 91, t114¼ 4.56, po0.0000; context: day 2,
t150¼ 4.00, p¼ 0.0001; day 30, t154¼ 4.86, po0.0000; day 90,
t114¼ 3.92, p¼ 0.0002; n¼ 76 animals/group; Figure 2a).
Enhanced fear generalization. We also examined how
these conditioned fear memories generalized to related
stimuli. The fear response to a different tone (400 Hz,
amplitude 1, 80 dB) or context (change of visual and odor
cues) in treated animals was measured. We found that both
groups expressed some fear when confronted with a
different tone or a different context, but fear generalization
was 24 and 45% greater in treated (n¼ 39) animals than
controls (n¼ 36), respectively (tone: t73¼ 3.49, p¼ 0.0008;
context: t73¼ 4.40, po0.0000; Figure 2b). We further
computed the freezing ratio of the nonconditioned (NS,
day 4) to the respective conditioned tone (day 3)
and context stimuli (CS, day 2; NS/CS¼ generalization
index¼GI). For both conditions, VPA-treated offspring
exhibited a significantly higher generalization index (tone:
Figure 1 Behavioral characterization of the VPA model autism. Offspring of VPA-treated dams exhibit (a), impaired social interactions (n¼ 10 pairs/
group) (b), enhanced repetitive behavior in the Y-maze (n¼ 43 control; n¼ 35 treated) (c), impaired thermal nociception in the hot plate test (n¼ 36
control; n¼ 39 treated) (d), normal startle response to a tone, but impaired PPI (n¼ 58 control; n¼ 56 treated) (e), increased anxiety in the EPM, but
normal broad locomotion (distance moved and velocity) (n¼ 59 control; n¼ 52 treated). Data show mean7SEM (*po0.05; **po0.01; ***po0.001).
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GI¼ 0.68 for control, GI¼ 0.87 for treated, t73¼ 3.26,
p¼ 0.001; context: GI¼ 0.44 for control, GI¼ 0.68 for
treated, t73¼ 3.26, p¼ 0.001). To address whether the
enhanced fear generalization to the tone might be due to
a ceiling effect in freezing, we further restricted the
generalization analysis to those VPA-treated animals with
the lowest freezing values (lower 50 and 30% of the VPA
data set). We found that, even when excluding the highest
freezing rats, the generalization index remained unchanged
for the VPA-treated offspring and was still significantly
different from the controls when considering the lower
freezing 50% of VPA-treated rats (GI¼ 0.86, t52¼ 2.33,
p¼ 0.02) and in tendency also when considering the lower
freezing 30% of the VPA-treated rats (GI¼ 0.86, t45¼ 1.79,
p¼ 0.08), indicating that the enhanced generalization was
not due to a ceiling effect. Thus, offspring of VPA-treated
rats not only exhibited hyperfear memories, but also once
conditioned overgeneralized fear to other NS.
Intact spatial learning and memory in the water maze. To
check whether the increased memory associated with the
amygdala was perhaps part of a general augmentation of
memory mechanisms in the brain, we tested the rats on
another memory task, the Morris water maze, which is
highly dependent on the hippocampus (Morris et al, 1982),
whereas it does not require the (basolateral) amygdala
(Roozendaal et al, 1998). Rats were trained to find a
submerged platform within four trials on each of four
consecutive days. We found no differences between treated
and control animals on any of the four training days or in a
subsequent probe trial (all: p40.05, n¼ 20 for control
and 18 for treated; Figure 2c). This may indicate that
hippocampus-dependent memories are spared in VPA-
treated animals, whereas amygdala-dependent fear mem-
ories are particularly affected in these animals.
Impaired fear extinction. Next, we asked whether the
enhanced fear memories could be extinguished in VPA-
treated rats as readily as in controls. For this purpose,
subgroups of animals were re-conditioned and underwent
several kinds of fear extinction trainings and an extinction
index was computed (freezing post-extinction/freezing pre-
extinction 100). First, we applied contextual extinction
training without any tone presentation. We found that in a
post-extinction test, treated (n¼ 17) animals still exhibited
57% of the pre-extinction freezing levels, whereas control
(n¼ 20) animals exhibited only 16% of the initial freezing
levels, thus indicating a severe impairment of treated
animals to extinguish the conditioning context (t35¼ 2.24,
p¼ 0.03; Figure 3a). Second, we attempted to extinguish the
fear to the tone, by presenting the tone repeatedly in the
same context as during the conditioning. In this configura-
tion, treated animals were again severely impaired in
extinguishing fear responses to the tone in the post-
extinction test (control: 4579% of pre-extinction freezing
to tone; treated: 79714% of pre-extinction freezing to tone;
t38¼ 2.14, p¼ 0.04; n¼ 20/group; Figure 3b). However,
when we attempted to extinguish the tone in a novel
context, the treated (n¼ 39) animals were able to unlearn
fear responses to the tone almost as well as controls (n¼ 36)
and exhibited only a tendency to impaired extinction
(control: 4374% of pre-extinction freezing to tone; treated:
5374% of pre-extinction freezing to tone; t73¼ 1.70,
p¼ 0.09; Figure 3c).
Figure 2 Enhanced fear memories and fear generalization. Offspring of VPA-treated dams exhibits (a), normal fear conditioning during training, but
enhanced fear memories to the tone and context 1, 30, and 90 days after training, with the differences becoming more pronounced with time (n¼ 76 pairs/
group) (b), enhanced fear generalization to a different tone and different context (n¼ 36 control; n¼ 39 treated) (c), normal to slightly impaired spatial
learning in the Morris Water Maze (n¼ 20 control; n¼ 18 treated). Data show mean7SEM (**po0.01; ***po0.001).
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In summary, amygdala-dependent fear memories were
greatly enhanced, overgeneralized to other stimuli and more
resistant to extinction in VPA-treated offspring, whereas
performance in an amygdala-independent learning and
memory task, spatial navigation in the water maze,
remained normal.
In Vitro Slice Electrophysiology in the Basolateral
Amygdala
To explore the possible cellular and synaptic changes in the
amygdala of the VPA animals, we performed in vitro slice
electrophysiological experiments on the LA, the sensory
relay station between the aversive shock and the condi-
tioned tone stimulus (LeDoux et al, 1990), and examined
how pyramidal neurons (Figure 4a) responded to stimula-
tion of the amygdala and how synaptic connections reacted
to a Hebbian pairing protocol.
Increased reactivity to stimulation. We found that strong
stimulation using MEA can activate the amygdala circuit to
produce reverberant activity that persists for seconds
without any further stimulation (Figure 4b). Therefore, we
compared these evoked activity states in control and VPA-
treated animals. For the equivalent stimulation, nearly
double the fraction of cells (83%) from VPA-treated animals
displayed this reverberant activity compared to 47% of cells
from control animals (control: 10 out of 21 cells; treated: 15
out of 18 cells, w21¼ 5.37, p¼ 0.02; Figure 4c). Furthermore,
among the cells displaying reverberant activity states, the
frequency of activity was significantly higher in treated rats
(t23¼2.39, p¼ 0.02; n¼ 15; Figure 4c).
Increased long-term potentiation. As synaptic plasticity in
the LA is thought to underlie fear memories (Quirk et al,
1995; Collins and Pare, 2000; Repa et al, 2001; Bauer et al,
2002), we also tested for LTP in VPA-treated rats. We found
that the potentiation caused by a classical pairing protocol
with an extracellular electrode placed just medial to the
LA was significantly increased in treated rats (t12¼ 3.12
p¼ 0.009; n¼ 15 for control, 10 for treated; Figure 4c).
Impaired inhibition. We finally examined the inhibitory
inputs into whole-cell patched principal neurons clamped at
a voltage equal to the reversal potential for AMPA receptors
(Vhold¼ + 10 mV), following MEA extracellular stimulation
with increasing amplitude. We measured the total inhibi-
tory current generated by a progressively greater stimulus
and compared the slices from VPA-treated animals with
those from the controls. The resulting stimulus–response
curve (Figure 4d) indicated that inhibition in the LA was
highly significantly decreased in VPA-treated rats as com-
pared to control rats (F1, 42¼ 10.50, p¼ 0.002, Figure 4d).
Due to excessive myelin formation with increasing age,
these experiments could not be performed at the same age
as the behavioral experiments, thus it cannot be entirely
excluded that that these cellular and synaptic effects might
recover with age.
In summary, the LA network of VPA-treated animals was
hyperreactive to stimulation and hyperplastic to intense
synaptic stimulation. Moreover, inhibition was impaired in
the LA.
DISCUSSION
In the present study, we show that a single injection of VPA
to pregnant rats on gestational day 12.5 yielded offspring
with a behavioral pattern strikingly similar to that observed
in autism. VPA-treated rat offspring exhibited symptoms
such as decreased social interactions, increased repetitive
behaviors, and less sensitivity to painFsome of the
hallmark features of autism. Locomotion levels and reac-
tions to simple auditory stimulation were normal in treated
animals, suggesting no motor or simple sensory impair-
ments. However, more complex auditory stimulation in the
prepulse inhibition paradigm revealed impaired sensori-
motor gating, which may be interpreted as impaired sensory
habituation and/or impaired response inhibition to com-
plex sensory input, and may lead to sensory overload and
the strong reactions to sensory stimulation, commonly
observed in autism. These results show that the VPA rat
model of autism is reproducible, as it is largely in
accordance with previous behavioral data (Schneider and
Przewlocki, 2005).
Figure 3 Impaired fear extinction. Depicted is the precentual decrease of post-extinction freezing from pre-extinction baseline levels. Offspring of VPA-
treated dams exhibits impaired fear extinction to (a), the conditioning context (n¼ 20 control; n¼ 17 treated) (b), a tone extinguished in the same context
as during conditioning (n¼ 20 pairs/group), but almost normal extinction when (c), the tone is extinguished in a novel context (n¼ 36 control; n¼ 39
treated). Data show mean7SEM (*po0.05).
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This study further provides the first clues that abnormal
anxiety and fear processing are significant behavioral features
of this animal model and could be a major factor shaping
behavior in autism. Fear memories were not only stronger
and longer lasting in VPA-treated offspring, but generalized
more to novel stimuli and were harder to extinguish.
The study also shows for the first time exaggerated
cellular responses to electrical stimulation, enhanced
synaptic plasticity, and a deficit in inhibition in the
amygdala. The hyperreactivity and hyperplasticity could
be due to the impaired inhibition in the treated rats.
We suggest that enhanced fear processing and memories
could perhaps underlie what has been considered to be
core symptoms of autism, such as impaired social inter-
actions and resistance to rehabilitation. These data also
support the view that enhanced, rather than weak amygdala
function, may be an important part of the pathology in
autism.
Figure 4 Increased network excitability, enhanced LTP and impaired inhibition in the LA. (a) Example of a principal cell of the LA and corresponding firing
pattern. (b) Response to multi-electrode array (MEA) network stimulation in a voltage-clamped (80 mV) pyramidal cell, illustrating the typical network
activity observed with this stimulation in control and VPA-treated offspring. The percentage of cells showing persistent reverberant activity is higher in
treated (15 out of 18 cells) than in control rats (10 out of 21 cells). Among the cells showing this activity, the frequency of reverberant events is higher in
treated than in control rats. (c) LTP is enhanced in treated rats. The left graph displays an example of the response amplitudes to extracellular stimulation
before and after the pairing protocol (represented by the gray bar), and the middle graph depicts mean amplitudes before and after pairing. The bar graph
represents the percentage increase in response amplitude after the pairing for control (n¼ 15) and treated (n¼ 10) rats. (d) The left graph shows a scheme
of MEA stimulation with 16 electrodes (50 Hz Poisson train, 300 ms) in principal cells of the LA. The right graphs display the inhibitory response curve of
principal cells voltage clamped at + 10 mV to MEA stimulation with increasing amplitude. In the upper left corner, the typical response of a single cell is
shown. The total area below the curve (charge) is measured for a series of different stimulation intensities. The inhibitory charge generated for all intensities
is significantly smaller in the VPA-treated animals. Data show mean7SEM (*po0.05; **po0.01).
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The VPA Rat Model of AutismFa Valid Model?
Animal models of disorders identified in humans, especially
disorders of high-level cognitive functions, are likely to
suffer from many shortcomings. Results from animal
models must therefore be interpreted with caution and
can only provide suggested new directions to facilitate
research of the disorder in humans. As an animal model of
autism, the VPA model seems to be the closest possible
insult-based model that allows a systematic study from the
synaptic to the behavioral level. Several case studies
(Christianson et al, 1994; Williams and Hersh, 1997;
Williams et al, 2001), as well as a population study (Moore
et al, 2000), reported a link between the administration of
the anticonvulsant drug VPA during pregnancy and the risk
of giving birth to an autistic child. Although several rodent
studies explored and established the teratogenic effects of
prolonged VPA administration during pregnancy in general
(Vorhees 1987a, b) and in the context of autism (Narita
et al, 2002; Wagner et al, 2006), we chose the VPA rat model
of autism proposed by Rodier et al (1996). This model
focuses specifically at the time of neural tube closure on
gestational day 12.5, which is believed to be a particularly
vulnerable time point for insults that may produce autistic
symptoms. Indeed, striking similarities were observed
between such VPA-treated rat offspring and autism,
including: (i) a reduced number of motor cells in cranial
nerve motor nuclei in the brain stem (Rodier et al, 1996),
(ii) a reduced number of Purkinje cells in the cerebellum,
observed both in VPA-treated offspring (Rodier et al, 1997;
Ingram et al, 2000) and autism (Ritvo et al, 1986; Kemper
and Bauman, 1998), (iii) decreased social interactions,
increased repetitive behaviors, lower sensitivity to pain,
impaired sensorimotor gating and increased anxiety
described in VPA-treated offspring (Schneider and
Przewlocki, 2005; Schneider et al, 2006) and commonly
found in the autistic spectrum (American Psychiatric
Association, 1994; Muris et al, 1998; McAlonan et al, 2002;
Perry et al, 2007).
Our results confirm many of the previous behavioral
findings on this particular VPA rat model of autism
(Schneider and Przewlocki, 2005; Schneider et al, 2006)
and show that this animal model is indeed reproducible.
Altogether, this cumulative evidence obtained with the VPA
rat model of autism indicates remarkable similarities with
the human autistic phenotype.
A Novel Role Suggested for the Amygdala in Autism
Both microscopic and macroscopic studies reveal altera-
tions in the morphology of the amygdala in autism (Kemper
and Bauman, 1998; Aylward et al, 1999; Sparks et al, 2002;
Schumann et al, 2004; Schumann and Amaral, 2006),
indicating a dysfunction in this region that might possibly
contribute to the autistic pathology. The current ‘amygdala
theory of autism’ is based on the lost capability to evaluate
socioemotional information and lost drive for social
interaction derived from lesioning studies in monkeys and
a few functional imaging studies in humans (Baron-Cohen
et al, 2000; Sweeten et al, 2002; Pelphrey et al, 2004;
Bachevalier and Loveland, 2006; Schultz, 2005), which
implies that a hypofunctioning amygdala underlies autism.
The amygdala is however also a crucial brain structure
implicated in mediating innate and acquired fear memories
as well as generalized anxiety (Davis and Whalen, 2001;
LeDoux, 2003). Even though the hypothesis that the
amygdala might underlie abnormal fear processing in
autism has been brought forward recently (Amaral et al,
2003; Schumann and Amaral, 2006), the present study is the
first to show that fear memories are greatly enhanced,
overly generalized to novel stimuli, and harder to extinguish
in an animal model of autism. These results are in fact also
consistent with some less cited autistic features such as
enhanced fears and phobias originally described by Kanner
(1943) and reported in some more recent studies (Muris
et al, 1998; Gillott et al, 2001; Evans et al, 2005). It is
however not clear if enhanced fears are common across the
autistic spectrum as some high-functioning autists do not
seem to display abnormal conditioned fear (Bernier et al,
2005).
We also found that behavioral alterations that could be
due to abnormal amygdala processing are indeed accom-
panied by direct physiological alterations in the lateral
complex of the amygdala. In particular, inhibition is
lowered and the circuit is hyperreactive when electrically
stimulated. Synaptic plasticity is also boosted suggesting
that the amygdala turned hyperplastic following a single
exposure of the embryo to VPA. Considering that LTP in
the basolateral amygdala is thought to be the key cellular
mechanism underlying fear memory formation (Quirk et al,
1995; Rogan et al, 1997; Collins and Pare, 2000; Repa et al,
2001; Bauer et al, 2002), hyperreactivity and hyperplasticity
are strong candidates mediating the enhanced and over-
generalized fear memories in the VPA-treated rats.
The amygdala also possesses a powerful inhibitory
interneuron system (Takagi and Yamamoto, 1981;
Washburn and Moises, 1992a, b), which tightly controls
neuronal activity and plasticity (Li et al, 1996; Szinyei et al,
2000; Bissiere et al, 2003; Shaban et al, 2006). In fact,
amygdalar disinhibition induced either by GABAergic
blockade (Isoardi et al, 2004), genetic knockout of the
GABAB(1a)-receptor subtype (Shaban et al, 2006), benzodia-
zepine withdrawal (Isoardi et al, 2004), dopamine receptor
activation (Bissiere et al, 2003), or stress (Rodriguez
Manzanares et al, 2005), can result in amygdaloid
hyperexcitability (Isoardi et al, 2004; Rodriguez Manzanares
et al, 2005) and facilitate LTP induction (Bissiere et al, 2003;
Rodriguez Manzanares et al, 2005; Shaban et al, 2006),
which have been associated not only with enhanced fear
memories (Isoardi et al, 2004; Rodriguez Manzanares et al,
2005), but also with overgeneralization of conditioned fear
to neutral stimuli (Shaban et al, 2006). These reports
suggest that the hyperreactivity and hyperplasticity ob-
served in this study may be due to a deficit in inhibition in
the amygdala. Indeed, we found a greatly reduced level of
inhibition during parallel electrical stimulation of the
amygdala.
Indirect Effects of Non-Amygdala Regions
The extinction of conditioned fear involves the amygdala
(Falls et al, 1992; Lu et al, 2001; Barad, 2006), as well as a
loop between the amygdala and the medial prefrontal cortex
(Sotres-Bayon et al, 2004, 2006). The prefrontal cortex gains
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increasing importance during the extinction process by
inhibiting amygdaloid responses to fear conditioned stimuli
(Rosenkranz et al, 2003), presumably through excitatory
projections on inhibitory neurons in the amygdala (Quirk
et al, 2003). A deficit in the inhibitory system in the
amygdala could therefore also compromise the effectiveness
of the projections from the prefrontal cortex in mediating
extinction. An alternative explanation is a deficit in the
medial prefrontal cortex itself. Indeed, the prefrontal cortex
was suggested to be crucially affected in autism (Bachevalier
and Loveland, 2006). A recent study however indicates that
the medial prefrontal cortex is also hyperreactive and
hyperplastic in VPA-treated offspring (TR & HM, unpub-
lished data), suggesting that the failure in extinction may be
more related to a loss of inhibition in the amygdala.
Contextual fear conditioning is dependent not only on the
amygdala, but also on the hippocampus (Phillips and
LeDoux, 1992), suggesting that the enhancement of CFC
found in the present study may be due to hyperfunctioning
of the hippocampus. Spatial learning and memory perfor-
mance using the Morris water mazeFa task which depends
on the hippocampus (Morris et al, 1982)Fwere however
not affected, further implicating hyperfunctioning of the
amygdaloid component in the fear conditioning data.
Further experiments are however required to determine
whether other forms of memories, such as reward-based,
rather than punishment-based, conditioning, are affected in
this animal model. Recent studies in our lab also indicate
that synaptic plasticity is greatly enhanced in the neocortex
of these VPA rats (Rinaldi et al, in press), thus it is possible
that memory tasks, which depend more on the neocortex,
are also enhanced. Further studies to test this hypothesis are
in progress.
Abnormal Amygdala Functioning and Fear
ProcessingFCore Symptom of Autism?
Hirstein et al (2001) suggested that an excessively
functioning amygdala may account for the increased
autonomic responses in autistic children (Hirstein et al,
2001; Corbett et al, 2006) and the consequent enhanced
stress may lead to their withdrawal from an overstimulating
world. The present study suggests that enhanced anxiety
and fear processing could perhaps further amplify an
aversion to complex environmental stimulation typical of
social conditions, leading to impaired social interactions
and resistance to rehabilitation. The presented data also
supports the view that enhanced, rather than weak
amygdala function may be part of the pathology in autism.
In accordance with these hypotheses are the findings that a
hyperreactive amygdala has been associated with social
phobia (Stein et al, 2002; Tillfors, 2004), whereas enhanced
sociability as encountered in Williams syndrome, is associ-
ated with a hyporesponsive amygdala (Meyer-Lindenberg
et al, 2005). A recent study screening for autism-like
symptoms in children with mood and anxiety disorders also
found that up to 62% of these children fall into the autistic
spectrum and might qualify for a possible diagnosis of
autism (Towbin et al, 2005). Thus, we would like to
speculate that enhanced amygdaloid processing in the
basolateral complex, possibly due to a failure in inhibition,
may account for enhanced fears (Isoardi et al, 2004;
Rodriguez Manzanares et al, 2005) and lead to a reduction
in social interactions. This is supported by a rodent study
showing that lesioning the BLA, the main relay station for
fear associations, impaired not only fear conditioningFa
well established finding (LeDoux et al, 1990)Fbut also led
to an increase, rather than a decrease, in social interactions
(Woolley et al, 2006). Thus, it is conceivable that an overly
active and plastic amygdala may produce enhanced anxiety
and fear processing, leading to social withdrawal to avoid
aversive, fear-evoking exposure.
Conclusion
This study provides the first experimental demonstration of
enhanced, overgeneralized and extinction-resistant condi-
tioned fear memories in a rat model of autism. These
behavioral symptoms may be caused by the hyperreactivity
and hyperplasticity discovered in the LA of VPA-treated
offspring, which may be due to impairments in the
inhibitory system of the amygdala. Therefore, we hypothe-
size that enhanced anxiety and fear processing in the
amygdala may contribute to an ‘aversive world’ syndrome
in autism, leading to withdrawal from social interactions
and resistance to rehabilitation. It is however important to
caution that this is only an animal model of autism and that
considerable amount of work still has to be performed to
determine the relevance of these findings to the human
condition.
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